EW

Edwards Lifesciences Corporation

HealthcareMedical - DevicesUSUSDPeers →

$88.58

LiveJun 16, 2026

AI Brief

Market cap

$51B

52w range

72.30 – 89.60

P / E

—

EPS · FY 2025

$1.83

Volume

4.66M

Revenue · FY 2025

$6.07B

+11.55% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Edwards Lifesciences Corporation’s valuation

decile 7 · 9% factors bull

News pulse · 14d

4 storiesPositive +0.87All news →

06-12today

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$86.28

Change

+17.76%

Period high

$88.16

Period low

$72.65

Period start

$73.272025-06-17

Through 2026-06-15

Fair value

Football field →

Weighted blend

$69.56

-21.47% vs spot

Recommendation

Sell

15 of 16 methods

Method spread

2bull11bear

±5% threshold

Analyst PT consensus: $96.53 (+8.97%)

Candlestick · 1Y

Open in chart workstation →

EW

86.28+17.76%

H 89.48L 72.30MA50 82.42MA200 81.78Avg vol 4.5M

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+2.67%	+2.94%	+8.85%	+6.01%	+3.82%	+3.91%	+18.39%	-3.65%	-11.54%	+167.59%	+6342.18%

Insider · 30d

History →

Bought

0 txns

Sold

$3.83M

10 txns

Net flow

−$3.83M

Aftermarket

Live

Jun 16, 11:53 PM

Last trade

$87.23

Bid

$87.23

20 sh

Ask

$90.00

238 sh

Spread

$2.770

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$1.65B	$380.7M	$0.66
Q4 Dec 2025	$1.57B	$91.2M	$0.16
Q3 Sep 2025	$1.55B	$291.1M	$0.50
Q2 Jun 2025	$1.53B	$329.8M	$0.56
Q1 Mar 2025	$1.41B	$358M	$0.61
Q4 Dec 2024	$1.39B	$385.6M	$0.65

Sector & industry today

Live

Sectors

Consumer Defensive
+0.72%
Technology
+0.67%
Real Estate
+0.47%
Energy
+0.45%
Industrials
-0.32%
Financial Services
-0.45%
Utilities
-0.49%
Healthcare
-0.92%
Consumer Cyclical
-0.94%
Basic Materials
-1.06%
Communication Services
-1.12%

Top industries (issuer's industry highlighted)

Medical - Devices
+0.34%
Broadcasting
-4.30%
Coal
+3.67%
Hardware, Equipment & Parts
-3.62%
Real Estate - Development
-3.31%
Trucking
-3.16%
Copper
-3.02%
Apparel - Manufacturers
-2.63%
Medical - Equipment & Services
-2.31%
Oil & Gas Energy
+2.28%
Conglomerates
-2.28%
Auto - Dealerships
-2.28%

Analyst view

DB · price_targets + analyst_grades

Consensus target

$96.53

+8.97% upside

Low

$85.00

Median

$95.00

High

$110.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

Recent analyst activity

1 latest

Jun 02, 2026GradeBuy → Buy'Edwards Lifesciences (EW) is our new Top-Pick'; PT Raised at TD CowenCowen & Co.

Peers

Total assets

$13.7B

Total debt

$705.4M

Cash & equiv

$2.94B

Operating CF

$1.6B

Free cash flow

$1.34B

Buybacks

-$893.4M

Recent insiders

All →

Insider	Action	Shares	Value	Date
Markowitz Wayne officer: CVP, JAPAC	Sell	593	$47.28K	May 11, 2026
Lippis Daniel J. officer: CVP, TAVR	Sell	1,019	$85.58K	May 04, 2026
Lippis Daniel J. officer: CVP, TAVR	Sell	19	$1.6K	May 01, 2026
Lippis Daniel J. officer: CVP, TAVR	Sell	1,000	$82.99K	May 01, 2026
Ullem Scott B. officer: CVP, Chief Financial Officer	Sell	4,676	$376.4K	Apr 09, 2026
Ullem Scott B. officer: CVP, Chief Financial Officer	Sell	8,324	$664.14K	Apr 09, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$6.07B	$1.64B	$1.07B	$1.83	+17.69%
FY 2024	$5.44B	$1.38B	$4.17B	$6.97	+76.75%
FY 2023	$5.01B	$1.43B	$1.4B	$2.30	+27.99%
FY 2022	$5.38B	$1.7B	$1.52B	$2.44	+28.28%
FY 2021	$5.23B	$1.61B	$1.5B	$2.38	+28.73%